Latest Breaking News On - Trendlines group - Page 1 : vimarsana.com

Trendlines Group Rights Issue Over-Subscribed

Trendlines Group (SG:42T) has released an update. The Trendlines Group Ltd. has announced the successful closure of its Rights Issue, achieving a 1.

Trendlines Group Holds Successful AGM

Has released an update. The Trendlines Group Ltd. successfully conducted its Annual General Meeting (AGM) on April 18, 202.

Limaca Medical Completes 24 EUS Pancreatic and Liver Biopsy Cases

Trendlines Group Insider Ups Holding During Year

ZygoFix Receives FDA Clearance for its zLOCK Lumbar Facet Fixation System

MISGAV, Israel, May 6, 2024 /PRNewswire/ ZygoFix Ltd. a portfolio company of The Trendlines Group Ltd. ("Trendlines") announced that it received regulatory clearance from the United States Food and

Trendlines Group Advances Rights Issue Plans

Has released an update. The Trendlines Group Ltd. has announced the receipt of the listing and quotation notice from the S.

Trendlines Group Broadcasts Corporate Milestones

Has released an update. The Trendlines Group Ltd. has published its FY2023 Annual Report and announced an upcoming Rights .

Trendlines Group Full Year 2023 Earnings: US$0.037 loss per share (vs US$0.017 loss in FY 2022)

Trendlines Group ( Catalist:42T ) Full Year 2023 Results Key Financial Results Net loss: US$34.0m (loss widened by 135.

Vessi Medical Closes $16.5M Series A Funding Round

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Bladder cancer treatment co Vessi Medical raises $16.5m

Vessi's minimally invasive solution for NMIBC provides a new therapeutic alternative to transurethral resection of bladder tumor.